SCHEDULE: Aurum Ventures Ups Stake in Polypid Ltd.

Aurum Ventures M.K.I. Ltd. has increased its beneficial ownership in Polypid Ltd. to 24.4% through the exercise of warrants.

Summary

• Aurum Ventures M.K.I. Ltd. has filed a Schedule 13G, indicating an increase in its beneficial ownership of Polypid Ltd. ordinary shares.
• The reporting person now beneficially owns 5,001,561 ordinary shares.
• This total includes 3,550,133 outstanding shares and 1,451,428 shares issuable under currently exercisable warrants.
• The percentage of the class beneficially owned is 24.4%, based on 19,083,236 outstanding shares as of February 19, 2026, plus the shares issuable from warrants.
• The filing notes that the reported ownership figures do not account for 'blocker' provisions in the warrants, which limit exercise to prevent beneficial ownership exceeding 9.9% at any given time. If these blockers were applied, the actual ownership would be lower.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports an increase in beneficial ownership due to warrant exercise, with a significant caveat regarding 'blocker' provisions that limit actual current ownership.

Positives

• Aurum Ventures M.K.I. Ltd. has increased its stake in Polypid Ltd., demonstrating continued investment and confidence.
• The company holds exercisable warrants that can increase its shareholding, providing potential for future growth in ownership.

Negatives

• The reported ownership percentage (24.4%) is reduced by 'blocker' provisions in the warrants, meaning the actual current ownership is less than stated.
• The 'blocker' provisions indicate a regulatory or strategic constraint on the maximum ownership level.

Risks

• The 'blocker' provisions in the warrants limit the reporting person's ability to exercise warrants if it would result in beneficial ownership exceeding 9.9% at any given time, potentially capping future ownership increases.
• The filing does not provide specific details on the underlying business performance of Polypid Ltd., only the ownership stake.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding Polypid Ltd.'s future performance. It solely focuses on the ownership stake of Aurum Ventures M.K.I. Ltd.

Management Comments

• All outstanding shares of Aurum are held indirectly by a trust settled by Morris Kahn (deceased).
• The trustee of the trust has appointed the board of directors of Aurum to make day-to-day voting and investment decisions with respect to the Ordinary Shares of the Issuer held by Aurum.
• The Ordinary Shares reported in Rows 5, 7 and 9, and the percentage shown in Row 11, reflect the number of Ordinary Shares that would be issuable upon full exercise of all such warrants beneficially owned by the Reporting Person (as all are currently exercisable) and do not give effect to 'blocker' clauses in the warrants that limit exercise of warrants to the extent it would result in beneficial ownership above 9.9% at any given time.
• If giving effect to such blockers, the actual number of Ordinary Shares that may be held by the Reporting Person at one time is less than the number of shares reported in Rows 5, 7 and 9, and the percentage ownership is less than that shown in Row 11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders to report their holdings. Aurum Ventures M.K.I. Ltd.'s increased stake in Polypid Ltd. suggests a notable investment position, potentially indicating confidence in Polypid's sector, which is likely in the medical device or pharmaceutical space given Polypid's known business.

Stakeholder Impact

• Shareholders of Polypid Ltd. may see the increased stake by Aurum Ventures M.K.I. Ltd. as a sign of confidence, though the 'blocker' provisions temper the immediate impact of the reported share increase.
• The trustee of the trust settled by Morris Kahn (deceased) and the board of directors of Aurum Ventures M.K.I. Ltd. are involved in the investment decisions.

Next Steps

• Aurum Ventures M.K.I. Ltd. will continue to manage its investment in Polypid Ltd. according to the decisions of its appointed board.
• The reporting person may exercise further warrants, subject to 'blocker' provisions.

Key Dates

Keywords

Polypid Ltd., Aurum Ventures M.K.I. Ltd., Schedule 13G, Beneficial Ownership, Ordinary Shares, Warrants, SEC Filing, Israel